Decoding schizophrenia.
Javitt
Daniel C
DC
Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute, Orangeburg, N.Y., USA.
Coyle
Joseph T
JT
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D003024:Clozapine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism; D010465:Perception; D010622:Phencyclidine / Q000494:pharmacology; D017470:Receptors, Glutamate / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D015398:Signal Transduction
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D010622:Phencyclidine; D003024:Clozapine; D004298:Dopamine